Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine
Article first published online: 11 APR 2012
© 2012 The Authors. Genes, Brain and Behavior © 2012 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society
Genes, Brain and Behavior
Volume 11, Issue 4, pages 404–414, June 2012
How to Cite
Piechota, M., Korostynski, M., Sikora, M., Golda, S., Dzbek, J. and Przewlocki, R. (2012), Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine. Genes, Brain and Behavior, 11: 404–414. doi: 10.1111/j.1601-183X.2012.00777.x
- Issue published online: 7 JUN 2012
- Article first published online: 11 APR 2012
- Accepted manuscript online: 5 MAR 2012 01:28PM EST
- Received 18 July 2011, revised 4 November 2011, 31 January 2012, and 17 February 2012, accepted for publication 28 February 2012
Additional Supporting Information may be found in the online version of this article:
Figure S1:Animal weight loss during chronic HER or METH treatment and withdrawal. The line graphs represent the weight of animals at three time-points: before the first injection (naive), 14 h after the last injection (chronic), and 12 days after the last injection (withdrawal) of METH (left), HER (middle) or SAL (right) using the diurnal (up) or nocturnal (down) treatment scheme. Single lines show single animals. Chronic diurnal treatment with both METH (P < 0.01) and HER (P < 0.05) caused a reduction in body weight. A more severe loss of body weight was observed following nocturnal chronic treatment with both METH (P < 0.001) and HER (P < 0.01).
Figure S2:Acquisition of locomotor sensitization to HER or METH after chronic treatment and withdrawal. The line graphs show the locomotor response to METH (2 mg/kg, left), HER (10 mg/kg, middle) or SAL (right) at three time-points. Responses to the first injection (Naive), 14 h after the last injection (Chronic), 12 days after the last injection (Withdrawal) using the diurnal (up) or nocturnal (down) treatment scheme are reported. Single lines show single animals.
Figure S3:Numbers of genes regulated by drug treatment. The Venn diagram represents numbers of probes significant for the main factors (drug, time) and interaction (Two-way ANOVA, FDR < 5%).
Figure S4:Dose-dependent effects of treatment on Hif3a gene and lack of the effect on Gm129 gene. Barplots show fold change of gene expression for every day of treatment and withdrawal in which the expression was measured. Scatterplots show dose effect on gene expression alteration of Hif3a (P < 0.05) and Gm129 (P > 0.05) genes.
Figure S5:Naloxone-precipitated withdrawal in mice following chronic treatment with METH or HER. Bar graphs summarising the mean and standard deviation of jumps in response to naloxone (s.c., 4 mg/kg) after the indicated treatment (n = 4–7). HER-treated mice exhibited significant withdrawal signs 14 h after the last injection (P < 0.05). METH-treated mice did not exhibit significant withdrawal signs 14 h after the last injection.
Table S1: Probes with uncorrected significance (P < 0.05).
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer-reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
|GBB_777_sm_fS1.pdf||101K||Supporting info item|
|GBB_777_sm_fs2.pdf||100K||Supporting info item|
|GBB_777_sm_fs3.pdf||51K||Supporting info item|
|GBB_777_sm_fs4.pdf||137K||Supporting info item|
|GBB_777_sm_fs5.pdf||160K||Supporting info item|
|GBB_777_sm_ST1.xls||1787K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.